Search - tctmd.com

Displaying 101 - 120 of 158

Sort: Relevancy | Date

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Daily News

Postconditioning Ineffective in STEMI Patients Receiving Primary PCI

Caitlin E. Cox

September 27, 2013

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Meta-analysis Questions Safety of Routine Blood Transfusion for AMI Patients

December 27, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

Presentation TCT 2012

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Presenter: Rajesh Dave

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

News Daily News

French Registry: Women with STEMI Fare Worse Than Male Counterparts

October 23, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

Advertisement

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Postconditioning Ineffective in STEMI Patients Receiving Primary PCI

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Meta-analysis Questions Safety of Routine Blood Transfusion for AMI Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

French Registry: Women with STEMI Fare Worse Than Male Counterparts

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content